Congress’s delay of new federal hemp restrictions protects near-term patient access and gives lawmakers more time to pursue a comprehensive policy that supports safety, clinical oversight and responsible state regulation.

AACPN welcomes House passage of legislation delaying most federal restrictions on consumable hemp products through December 11, providing Congress additional time to develop a comprehensive regulatory framework.

Originally published by the Hartford Courant, John R. Gordon examines Connecticut’s approach to hemp regulation amid an evolving national policy debate and considers the implications of proposed federal restrictions for the state’s existing regulatory framework.

Originally published in the Hartford Courant, this op-ed examines Connecticut's Public Act 26-108 and its implications for psychedelic-assisted therapy, evidence-based healthcare innovation, and patient access.